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ABSTRACT
Introduction: Primary motor cortical (M1) adaptation
in the form of altered organisation and function is
hypothesised to underpin motor dysfunction observed
in chronic pain. The aim of this review is to assess the
evidence for altered M1 organisation and function in
chronic pain.
Methods and analysis: Systematic review and meta-
analysis. We will search electronic databases with
predetermined search terms to identify relevant studies
and evaluate the studies for inclusion and risks of bias.
Two independent reviewers will extract data. Any
disagreement will be resolved through a third reviewer.
Cross-sectional or prospective studies published in
English before May 2015 that investigate M1
organisation and function in chronic pain will be
included if they meet the eligibility criteria. Primary
outcomes will include M1 cortical excitability, spatial
cortical representation, the function of inhibitory and
facilitatory intracortical networks, cortical reactivity and
cortical glucose metabolism. Clinical measures such as
pain and disability will be included where the
correlation with the primary outcomes of M1
organisation and function were investigated in the
included studies.
Ethics and dissemination: This systematic review
does not require ethical approval. The results of this
review will be submitted for peer-reviewed publication
regardless of outcome and will be presented at relevant
conferences.
Trial registration number: Our systematic review
protocol was registered with the International
Prospective Register of Systematic Reviews
(PROSPERO; registration number CRD42015014823).
INTRODUCTION
Musculoskeletal disorders are a common
cause of disability and result in signiﬁcant
social and economic costs.1 An estimated
10%, 5% and 4% of the global population
with low back pain (LBP), neck pain and
knee osteoarthritis, respectively, live with
disability1 with pain being the main symptom
of musculoskeletal disorders, especially in
the chronic stage. In the USA, nearly 30% of
the adult population live with pain.2
Movement dysfunction associated with
pain is commonly observed in the clinic and
is a key focus of rehabilitation. For instance,
when musculoskeletal pain is present, deﬁcits
in force production, amplitude and speed of
movement, muscle coordination and postural
control are reported.3–5 Despite this, the
physiological basis and clinical relevance of
movement dysfunction in pain is poorly
understood. There is considerable debate
regarding the type, quantity and timing of
movement-based treatments, if any, needed
to effectively target motor dysfunction in per-
sistent musculoskeletal pain disorders.6–8
The primary motor cortex (M1) is a key
driver of motor output and may therefore
contribute to movement dysfunction in pain,
making it a potential target for therapy.
There is emerging evidence of altered M1
organisation and function across a range of
chronic pain conditions. For example, M1
topographical representations generated
using transcranial magnetic stimulation
(TMS) show greater overlap and a reduced
Strengths and limitations of this study
▪ Altered organisation and function of primary
motor cortex (M1) is implicated in chronic pain.
However, to the best of our knowledge, this is
the first systematic review of M1 changes across
multiple chronic pain conditions.
▪ Two independent reviewers will assess articles
for inclusion and conduct data extraction and
risk of bias assessment.
▪ Data analyses will include meta-analyses where
appropriate, as well as subgroup and sensitivity
analyses.
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number of discrete peaks in chronic low back9–11 and
elbow pain,12 and these changes are associated with pain
severity and/or motor dysfunction. Similarly, there is evi-
dence for increased signal with movement of the
affected hand in complex regional pain syndrome
(CRPS) using functional MRI13 and evidence of reduced
GABAergic and glutamatergic M1 function in ﬁbromyal-
gia that is associated with fatigue.14
To our knowledge, only one published systematic
review has investigated M1 organisation and function in
chronic pain, and this was restricted to CRPS.15 That
review revealed limited evidence of bilateral M1 disinhib-
ition in CPRS of the upper limb.15 However, it is
unknown whether similar alterations in M1 are present
in other forms of chronic pain. Indeed, one previous
study has suggested that M1 disinhibition may occur in
chronic neuropathic but not chronic nociceptive pain.16
This review will be the ﬁrst to systematically and critically
evaluate the evidence for altered M1 organisation and
function, across a range of measurement tools, in
chronic pain conditions of neuropathic and non-
neuropathic origin. Understanding how M1 organisation
and function is altered in chronic pain is essential to
inform the design and testing of treatment strategies
that seek to target M1 in pain.
Here, we present the protocol for a review that aims to
evaluate the evidence for altered M1 organisation and
function in chronic pain conditions of neuropathic or
non-neuropathic origin. This protocol is prepared
according to the Preferred reporting items for systematic
review and meta-analysis protocols (PRISMA-P) guide-
lines.17 The protocol was registered with the
International Prospective Register of Systematic Reviews
(PROSPERO; registration number CRD42015014823).
METHODS AND ANALYSIS
Review question
What is the evidence for altered M1 organisation and
function in chronic pain conditions of neuropathic and
non-neuropathic origin?
Search strategy
The methods for this systematic review have been devel-
oped according to the MOOSE Guidelines for
Meta-Analyses and Systematic Reviews of Observational
Studies.18 The search strategy will be implemented in
two stages.
1. Searches will be conducted in PubMed, MEDLINE,
EMBASE, PsychINFO and CINAHL databases to iden-
tify relevant literature. Key words and medical subject
headings (MeSH) related to chronic pain, neuroima-
ging and the brain will be used; for example: chronic
pain, positron emission tomography, functional mag-
netic resonance imaging, BOLD contrast,
Electroencephalogra*, Magnetoencephalogra*, tran-
scranial magnetic stimulation, motor cortical and sen-
sorimotor cortex. The full search terms are listed in
online supplementary appendix 1. The combination
of chronic pain, neuroimaging and brain search terms
will be used in varying combinations to identify rele-
vant literature. Search strategies will be customised to
suit each database. The main search strategy is
included in online supplementary appendix 1.
2. The reference lists of eligible articles and relevant
reviews will be manually searched for additional
articles.
Type of participants
Participants should be adults (aged over 18 years)
experiencing chronic, musculoskeletal pain of neuro-
pathic or non-neuropathic origin. Neuropathic pain is
deﬁned as ‘pain caused by a lesion or disease of somato-
sensory nervous system’.19 Non-neuropathic pain is
deﬁned as pain without an identiﬁable lesion or disease
of the somatosensory nervous system.20 Studies investi-
gating visceral or cancer pain will be excluded. No
restriction is placed on the sex of participants. The dur-
ation of pain experienced by participants should be
greater than 3 months as this duration is commonly
deﬁned as the chronic phase of pain.21 Cross-sectional
or prospective studies will be included in the initial
search if they meet the eligibility criteria. Prospective
studies including case–control and randomised con-
trolled trials will only be included if their baseline data
provide information relevant to the review objective.
Inclusion criteria
1. Full-text studies, including in press or accepted
studies, published in English prior to May 2015.
2. Studies conducted on adult humans with chronic
non-neuropathic or neuropathic pain.
3. Studies that investigate the organisation and/or func-
tion of the M1 (regardless of the anatomical or func-
tional deﬁnition used) with the following techniques:
TMS, MRI, positron emission tomography, EEG and
magnetoencephalography.
4. Studies including data from a healthy control group.
Exclusion criteria
1. Studies including participants with chronic pain not
of musculoskeletal origin, for example, pain asso-
ciated with spinal cord injury, stroke, cancer or vis-
ceral pain.
2. Studies that do not include a healthy control group
or that use the unaffected limb or body side as a
control. It is recognised that widespread symptoms
remote from the original injury site can be observed
in chronic pain.22 Thus, using an unaffected limb or
body side as a comparison is not considered an
appropriate control.
Primary outcomes
Eligible studies should report one of the following mea-
surements of M1 organisation and/or function: cortical
excitability, spatial representations, inhibitory or
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facilitatory intracortical networks, reactivity and/or
glucose metabolism as outcomes for analysis in this
review. Clinical measures such as pain and disability will
be included where these are correlated with the primary
outcomes of M1 organisation and function.
Data management
Two reviewers will independently evaluate the title and
abstract of all studies identiﬁed through the search
against the inclusion and exclusion criteria. Any dupli-
cate studies will be removed. The full text of all eligible
studies will then be retrieved. EndNote X7 will be used
during the review process to avoid duplicating refer-
ences. If the reviewer is uncertain about the eligibility of
any study, its full text will be obtained for further infor-
mation. An additional reviewer will be consulted should
there be any uncertainty or disagreement of the eligibil-
ity of studies. Excluded studies and the reasons for
exclusion will be recorded.
Data extraction
A customised data extraction form (see online supple-
mentary appendix 2) will be piloted on two studies not
directly related to this review, and then used to extract
data. Two independent reviewers will conduct data
extraction. Any disagreements will be resolved through a
third reviewer. The following data will be extracted: (1)
participant-speciﬁc data such as condition, duration and
severity of chronic pain, sample size in each group, sex
and age; (2) neurophysiological methods and outcomes,
speciﬁcs of the investigative model such as type and loca-
tion of stimulation, how M1 was anatomically or func-
tionally deﬁned, neuroimaging ﬁndings in M1
excitability, representation, reactivity and glucose metab-
olism; (3) pain scores. Other outcome measurements
such as quantitative sensory tests and movement dysfunc-
tion will be extracted if they are correlated with the
primary outcomes. If data are missing, authors will be
contacted a maximum of three times, after which the
data will be considered irretrievable.
Risk of bias (quality) assessment
To assess the risk of bias of the included studies, we will
use the STROBE statement for cross-sectional and cohort
studies (see online supplementary appendix 3) and
items relevant to case–control studies from the Cochrane
Collaboration tool for assessing the risk of bias.23–25
Methodological quality pertaining directly to the use of
TMS will be assessed via a TMS methodological checklist
(see online supplementary appendix 4).26 Two inde-
pendent reviewers will undertake the assessment of risk
of bias and methodological quality. Any disagreement
will be resolved by a third reviewer.
Strategy for data synthesis
A quantitative synthesis is planned to aggregate the data
from all types of chronic pain conditions. Parameters
such as cortical excitability (resting or active motor
thresholds, intracortical inhibition, intracortical facilita-
tion), spatial representation (map volume, BOLD
response), M1 reactivity or M1 glucose metabolism will
be pooled to perform separate meta-analyses using
OpenMetaAnalyst. Cohen’s d effect sizes will be used to
analyse effect estimates: d≤0.2 is small, 0.5 represents
medium, ≥0.8 is considered large.27 Data will be pooled
for an outcome by using a random-effects model if data
from at least two studies addressing that outcome are
accessible. The χ2 test will be used to identify statistically
signiﬁcant heterogeneity, and statistically signiﬁcant het-
erogeneity will be considered existent when χ2 p<0.10.
The I2 statistic will be used to evaluate the degree of het-
erogeneity. Substantial heterogeneity will be considered
existent when I2 >50%.28 All data will be presented as
effect estimates (with 95% CIs). Where quantitative syn-
thesis of the extracted data is not appropriate, a narrative
synthesis will be used to summarise the study ﬁndings
about functional and structural changes of M1.17
Analysis of subgroups or subsets
Where signiﬁcant heterogeneity is found, we will
conduct subgroup analysis according to the type of pain
conditions (LBP, CRPS, ﬁbromyalgia, peripheral neuro-
pathic pain or peripheral tendinopathy), duration of
pain, sex of participants and type of treatment partici-
pants were receiving at the time cortical data were
collected.
Sensitivity analysis
The included studies will be given a score when asses-
sing their methodological quality. For example, studies
will score one point if they meet the criteria of 1 of the
22 items from the STROBE statement, hence a
maximum 22 points can be scored. The median value of
the overall scores of eligible studies will be used as the
cut-off point to divide the studies into either the low or
high risk of bias group. We will then examine the inﬂu-
ence of including studies at high risk of bias by running
the analysis with those studies excluded.
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